XML 52 R41.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Stock Options - SARs (Details) - USD ($)
3 Months Ended 6 Months Ended
Apr. 18, 2022
Jun. 30, 2024
Jun. 30, 2023
Jun. 30, 2024
Jun. 30, 2023
Dec. 31, 2023
Stock option details            
Number of rights issued       8,000    
Base value of units issued (per unit)       $ 53.91    
SARs            
Outstanding beginning balance       465,250    
Granted       8,000    
Forfeited       (11,500)    
Outstanding ending balance   461,750   461,750    
Weighted average exercise price            
Weighted average exercise price, beginning balance (per share)       $ 39.35    
Weighted average exercise price, granted (per share)       53.91    
Weighted average exercise price, forfeited (per share)       39.33    
Weighted average exercise price, ending balance (per share)   $ 39.60   $ 39.60    
Aggregate intrinsic value            
Aggregate intrinsic value   $ 8,130,000   $ 8,130,000    
Weighted average remaining contractual term (years)       8 years 14 days    
Stock Appreciation Rights (SARs)            
Aggregate intrinsic value            
Fair Value of Liability   2,888,000   $ 2,888,000   $ 1,464,000
Stock-based compensation expense   344,000 $ 264,000 1,424,000 $ 430,000  
Stock-based compensation cost, unrecognized   $ 7,311,000   $ 7,311,000    
Stock-based compensation cost, unrecognized, weighted-average period of recognition       8 years    
Stock Appreciation Rights (SARs) | SAR Plan            
Stock option details            
Shares available for future grants 750,000          
Maximum exercisable period for granted share-based compensation 10 years          
Number of rights issued       461,750    
Vesting period 8 years          
SARs            
Granted       461,750